Enter your email address below and subscribe to our newsletter

Technology

Share your love

Meeting expectations with evolving technology

(Image Credit: AdobeStock) As an ophthalmology resident, I am increasingly meeting patients who underwent LASIK surgery 15 or 20 years ago. They were the early adopters of refractive surgery, thrilled to toss their glasses in their youth. Now in their…

The potential of AI in retina with Daniela Ferrara

This conversation features Daniella Ferrara, Chief Medical Officer for TopCon Healthcare, discussing the transformative potential of artificial intelligence in retinal imaging and ophthalmology. Ferrara, an ophthalmologist and retina specialist with 25 years of experience in retinal imaging innovation. The discussion…

Alcon presenting at APACRS 2025

(Image credit: ©RealityImages/AdobeStock) Alcon announced presentations during the 37th Asia-Pacific Association of Cataract and Refractive Surgeons (APACRS) Annual Meeting. The company will showcase four symposia, lead 10 medical affairs scientific exchange presentations, and offer a hands-on experience zone booth.1 APACRS…

Innovative VR Solution for Cataract Surgery Training

At the annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS) in Boston, Orbis International, together with FundamentalVR, introduced a virtual reality (VR) training tool. This immersive VR solution is especially designed for use in low- and…

The Pineal Gland & The Eye of Horus I OBN

Since Galen, a Greek physician and philosopher, first recorded information on the pineal gland’s significance, it has been the focus of extensive research. Colleagues of Galen held the opinion that the pineal controlled the movement of “psychic pneuma,” an ethereal substance…

Zeiss Completes Acquisition of DORC

In a significant move for the ophthalmology sector, Carl Zeiss Meditec announced the successful acquisition of 100% shares of the Dutch Ophthalmic Research Center (DORC), a transaction that has now received all necessary regulatory approvals. This acquisition from Eurazeo SE,…

Melt Pharma Raises $24M for Sedation Tablet

Melt Pharmaceuticals has successfully completed a significant financial milestone, securing approximately $24 million through its Series B Preferred Stock financing round. This latest funding round saw contributions from both new and returning investors, setting the stage for the accelerated development…

Stay informed and not overwhelmed, subscribe now!